Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Surgical challenges to retroperitoneal sarcomas

Clinical trials and drug developments in pancreatic cancer

The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery

MET inhibitors for non-small cell lung cancer

Treatment of ALK+ lung cancer with crizotinib, Profile 1007

The first phase II trial for the management of oesophageal cancer

Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer

Personalised cancer medicine and research: Today’s best practice

Treating liver metastases in colorectal cancer

Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study

The Multinational Association of Supportive Care in Cancer (MASCC)